KERX
Congressional Trades
Whale Activity
No 13F positions in KERX among the institutional filers we track.
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
No open-market insider buys or sells in the last two years.
Recent Insider Transactions
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| BAUPOST GROUP LLC/MADirector · 10% owner | Disposition to issuer | −65.4M | — | — | Dec 12, 2018 | Form 4 ↗ |
| ROGERS MICHAEL WDirector | Disposition to issuer | −30.0K | — | — | Dec 12, 2018 | Form 4 ↗ |
| Enyedy Mark JDirector | Disposition to issuer | −10.0K | — | — | Dec 12, 2018 | Form 4 ↗ |
| Holmes Scott AChief Financial Officer | Disposition to issuer | −163.0K | — | — | Dec 12, 2018 | Form 4 ↗ |
| Morrison Jodie PopeInterim CEO · Director | Disposition to issuer | −120.0K | — | — | Dec 12, 2018 | Form 4 ↗ |
| Regan Daniel PaulDirector | Disposition to issuer | −60.0K | — | — | Dec 12, 2018 | Form 4 ↗ |
| Heffernan Michael ThomasDirector | Disposition to issuer | −20.0K | — | — | Dec 12, 2018 | Form 4 ↗ |
| GILMAN STEVEN CDirector | Disposition to issuer | −27.3K | — | — | Dec 12, 2018 | Form 4 ↗ |
| Neylan John F.Chief Medical Officer | Disposition to issuer | −148.3K | — | — | Dec 12, 2018 | Form 4 ↗ |
| Cameron Kevin JDirector | Disposition to issuer | −186.7K | — | — | Dec 12, 2018 | Form 4 ↗ |
| Carberry Christine A.Chief Operating Officer | Disposition to issuer | −100.6K | — | — | Dec 12, 2018 | Form 4 ↗ |
| BAUPOST GROUP LLC/MADirector · 10% owner | Grant / award | +4.0M | — | — | Dec 11, 2018 | Form 4 ↗ |
| BAUPOST GROUP LLC/MADirector · 10% owner | Grant / award | +35.6M | $4.63 | $164.7M | Dec 11, 2018 | Form 4 ↗ |
| Carberry Christine A.Chief Operating Officer | Sale | −10.5K | $3.22 | $34K | Dec 11, 2018 | Form 4 ↗ |
| Neylan John F.Chief Medical Officer | Sale | −1,156 | $2.77 | $3K | Nov 15, 2018 | Form 4 ↗ |
| Holmes Scott AChief Financial Officer | Sale | −1,155 | $2.77 | $3K | Nov 15, 2018 | Form 4 ↗ |
| Neylan John F.Chief Medical Officer | Sale | −1,253 | $3.07 | $4K | Oct 29, 2018 | Form 4 ↗ |
| Holmes Scott AChief Financial Officer | Sale | −1,254 | $3.07 | $4K | Oct 29, 2018 | Form 4 ↗ |
| Carberry Christine A.Chief Operating Officer | Sale | −2,040 | $3.29 | $7K | Oct 18, 2018 | Form 4 ↗ |
| Holmes Scott AChief Financial Officer | Sale | −1,185 | $3.04 | $4K | Aug 15, 2018 | Form 4 ↗ |
Fund Holders
Funds report their holdings by CUSIP, and KERX could not be matched to one, so no fund holdings are shown.
Activist & Passive Stakes
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
No lobbying filings found naming KERX as the client.
Government Contracts
No federal contract awards found for KERX.
U.S. Patents
No USPTO patent applications found for KERX.
Annual Financials
No annual XBRL figures on record for KERX. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
No price history on record for KERX.
Material Events (8-K)
No 8-K filings on record.
About KERX
No company profile on record.